FDA Device Intelligence
HomeINSTRUMENTATION LABORATORY COMPANY › HemosIL Thrombin Time

HemosIL Thrombin Time

INSTRUMENTATION LABORATORY COMPANY · Model 00009758515 · UDI-DI 08426950058366

GJA Prescription
1
510(k) clearances
15
Adverse events
4
Recalls
7
Facilities

Description

HemosIL Thrombin Time

Recalls

DateFirmReason
2017-10-17Siemens Healthcare DiagnosticsThe BC Thrombin Reagent kit lot 46751 (contains Thrombin Reagent lot 517468) and kit lot 47184 (contains Thrombin Reagent lot 517469) produce unexpected prolonged Thrombin Time (TT
2004-08-20bioMerieuxComplaints were received from the field regarding prolonged clot times, high control values and erratic results.
2004-08-20bioMerieuxComplaints were received from the field regarding prolonged clot times, high control values and erratic results.
2004-07-21Dade Behring , Inc.The product does not demonstrate the expected prolonged thrombin times for specimens obtained from patients recieving heparin

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.